The impact of kyphosis on daily functioning

Journal of the American Geriatrics Society

Volumn 45, Issue 12, 1997, Pages 1479-1486

  Ryan, Stephen D ^a,b   Fried, Linda P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTHRITIS; ARTICLE; CLIMBING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; SCOLIOSIS; SELF REPORT; SEX DIFFERENCE; VERTIGO; WALKING;

EID: 0030778829     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03199.x     Document Type: Article

References (52)

1. Sinaki M. Exercise and physical therapy. In: Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. New York: Raven Press; 1988:457-479.
2. Edmondston SJ, Singer KP, Price RI et al. The relationship between bone mineral density, vertebral body shape and spinal curvature in the elderly thoracolumbar spine: An in vitro study. Br J Radiol 1994;67:969-975.
3. Melton LJ, 3rd, Kan SH, Frye MA et al. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129:1000-1011.
4. Kiel DP, Felson DT, Anderson JJ et al. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987;317:1169-1174.
5. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone 1993;14 (suppl 1): S89-97.
6. Melton LJ, 3rd, Lane AW, Cooper C et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3:113-119.
7. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-227.
8. Ettinger B, Black DM, Palermo L et al. Kyphosis in older women and its relation to back pain, disability and osteopenia: The study of osteoporotic fractures. Osteoporos Int 1994;4:55-60.
9. Ettinger B, Black DM, Nevitt MC et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1992;7:449-456.
10. Ryan PJ, Blake G, Herd R, Fogelman I. A clinical profile of back pain and disability in patients with spinal osteoporosis. Bone 1994;15:27-30.
11. Ross PD, Davis J\V, Epstein RS, Wasnich RD. Pain and disability associated with new vertebral fractures and other spinal conditions. J Clin Epidemiol 1994;47:231-239.
12. Greendale GA, Barren-Connor E, Ingles S, Halle R. Late physical and functional effects of osteoporotic fracture in women: The Rancho Bernardo Study. J Am Geriatr Soc 1995;43:955-961.
13. Lyles KW, Gold DT, Shipp KM et al. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 1993;94:595-601.
14. Liberman UA, Weiss SR, Broil J et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopaijsal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Croup. N Engl J Med 1995;333:1437-1443.
15. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroidinduced osteoporosis. Am J Med 1995;99:235-242.
16. Eastell R, Cedel SL, Wahner HW et al. Classification of vertebral fractures. J Bone Miner Res 1991;6:207-215.
17. Ross PD, Yhee YK, He YF et al. A new method for vertebral fracture diagnosis. J Bone Miner Res 1993;8:167-174.
18. Smith-Bindman R, Cummings SR, Steiger P, Genant HK. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res 1991;6:25-34.
19. Milne JS, Williamson J. A longitudinal study of kyphosis in older people. Age Ageing 1983;12:225-233.
20. Melton LJ, 3rd, Cummings SR. Heterogeneity of age-related fractures: Implications for epidemiology. Bone Miner 1987;2:321-331.
21. Ross PD, Huang C, Davis JW, Wasnich RD. Vertebral dimension measurements improve prediction of vertebral fracture incidence. Bone 1995;16:257-262S.
22. Smith-Bindman R, Steiger P, Cummings SR, Genant HK. The index of radiographic area (IRA): A new approach to estimating the severity of vertebral deformity. Bone Miner 1991;15:137-149.
23. Singer KP, Jones TJ, Breidahl PD. A comparison of radiographie and computer-assisted measurements of thoracic and thoracolumbar sagittal curvature. Skeletal Radiol 1990;19:21-26.
24. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J PsychiatrRes1975;12:189-198.
25. Fried LP, Bandeen-Roche K, Williamson JD et al. Functional decline in older adults: Expanding methods of ascertainment. J Gerontol 1996;51:M206-214.
26. Fitti JE, Kovar MG. The Supplement on Aging to the 1984 National Health Interview Survey. Vital Health Stat [1] 1987, pp 1-115.
27. Maigne R. General Principles. In: Maigne R, ed. Diagnosis and Treatment of Pain of Vertebral Origin. Baltimore: Williams & Wilkins, 1996, pp 131-133.
28. Altman DG. Practical Statistics for Medical Research. New York: Chapman & Hall, 1991.
29. The SAS System for Microsoft Windows. (6.10.) Gary, NC: SAS Institute Inc., 1993.
30. Guralnik JM, LaCroix AZ, Abbott RD et a1. Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol 1993;137:845-857.
31. 31.'Ettinger WH, DavisMA, Neuhaus JM, Malion KP. Long-term physical functioning in persons with knee osteoarthritis from NHANES. I: Effects of comorbid medical conditions. J Clin Epidemiol 1994;47:809-815.
32. Verbrugge LM. Disability transitions for older persons with arthritis. J Aging Health 1992;4:212-243.
33. Verbrugge LM, Jette AM. The disablement process. Soc Sei Med 1994;38:1-14.
34. Nagi SZ. Disability concepts revisited: Implications for prevention. In: Pope AM, Tarlov AR, eds. Disability in America: Toward a National Agenda for Prevention. Washington, DC: National Acadamy Press, 1991 pp 309-327.
35. Reuben DB, Siu AL, Kimpau S. The predictive validity of self-report and performance-based measures of function and health. J Gerontol 1992;47:M106-110.
36. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-94.
37. Rozzini R, Frisoni GB, Bianchetti A et al. Physical performance test and activities of daily living scales in the assessment of health status in elderly people. J Am Geriatr Soc 1993;41:1109-1113.
38. Guralnik JM, Ferrucci L, Simonsick EM et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:55fi-561.
39. Gill TM, Williams CS, Tinetti ME. Assessing risk for the onset of functional dependence among older adults: The role of physical performance. J Am Geriatr Soc 1995;43:603-609.
40. Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fractures. Bone 1994;15:377-386.
41. Avioli LV. Significance of osteoporosis: A growing international health care problem. Calcif Tissue Int 1991;49(suppl):5-7S.
42. Barrett-Connor E. The economic and human costs of osteoporotic fracture. AmJMedl995;98:3-8S.
43. Bone HG, Downs RWJr, TucciJR et al. Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers. J Clin Endocrinol Metab 1997;82:265-274.
44. Tucci JR, Tonino RP, Emkey RD et al. Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 1996;101:488-501.
45. Siminoski K, Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis. Can Med Assocj 1996;155:962-965.
46. Jones G, Hogan DB, Yendt E, Hanley DA. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. Can Med Assoc J 1996;155:955-961.
47. Murray TM, Ste-Marie LG. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis. Can Med Assoc J 1996;155:949-954.
48. Hodsman A, Adachi J, Olszynski W. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis. Can Med Assoc J 1996;155:945-948.
49. Weinstein JN, Collalto P, Lehmann TR. Thoracolumbar "burst" fractures treated conservatively: A long-term follow-up. Spine 1988;13:33-38.
50. Riggs BL, Hodgson SF, O'Fallon WM et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802-809.
51. Sambrook PN. Treatment of postmenopausal osteoporosis. N Engl J Med 1995;333:1495.
52. Overgaard K, Hansen MA, Jensen SB, Christiansen C. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: A dose-response study. Br Med J 1992;305:556-561.